TY - JOUR AU - Baji, Petra AU - Pavlova, M AU - Gulácsi, László AU - Groot, W TI - User fees for public health care services in Hungary: expectations, experience, and acceptability from the perspectives of different stakeholders JF - HEALTH POLICY J2 - HEALTH POLICY VL - 102 PY - 2011 IS - 2-3 SP - 255 EP - 262 PG - 8 SN - 0168-8510 DO - 10.1016/j.healthpol.2011.03.001 UR - https://m2.mtmt.hu/api/publication/2068725 ID - 2068725 N1 - Megjegyzés-21966588 : FN Thomson Reuters Web of Knowledge Megjegyzés-21966158 : FN Thomson Reuters Web of Knowledge Megjegyzés-21965836 : FN Thomson Reuters Web of Knowledge AB - OBJECTIVE: The introduction of user fees for health care services is a new phenomenon in Central-Eastern European Countries. In Hungary, user fees were first introduced in 2007, but abolished one year later after a referendum. The aim of our study is to describe the experiences and expectations of health system stakeholders in Hungary related to user fees as well as their approval of such fees. METHOD: For our analysis we use both qualitative and quantitative data from focus-group discussions with health care consumers and physicians, and in-depth interviews with policy makers and health insurance representatives. RESULTS: Our findings suggest that the reasons behind the unpopularity of user fees might be (a) the rejection of the objectives of user fees defined by the government, (b) negative personal experiences with user fees, and (c) the general mistrust of the Hungarian population when it comes to the utilization of public resources. CONCLUSION: Successful policy implementation of user fees requires social consensus on the policy objectives, also there should be real improvements in health care provision noticeable for consumers, to assure the fees acceptance. LA - English DB - MTMT ER - TY - JOUR AU - Gaál, Péter AU - Szigeti, Szabolcs AU - Csere, Márton AU - Gaskins, Matthew AU - Panteli, Dimitra TI - Hungary: Health system review JF - Health systems in transition J2 - Health systems in transition VL - 13 PY - 2011 IS - 5 SP - 1 EP - 266 PG - 266 SN - 1817-6127 UR - https://m2.mtmt.hu/api/publication/1786251 ID - 1786251 LA - English DB - MTMT ER - TY - JOUR AU - Inotai, András AU - Merész, Gergő AU - Kaló, Zoltán TI - A magyar gyógyszerkiadások nagyságának értékelése-Assessment of the pharmaceutical expenditure in Hungary JF - ACTA PHARMACEUTICA HUNGARICA J2 - ACTA PHARM HUNG VL - 80 PY - 2010 IS - 4 SP - 162 EP - 172 PG - 11 SN - 0001-6659 UR - https://m2.mtmt.hu/api/publication/1496884 ID - 1496884 N1 - Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Hogyes E. u. 9, Budapest, 1092, Hungary Syreon Kutató Intézet, Thököly út 119, Budapest, 1146, Hungary Eötvös Loránd Tudományegyetem, Társadalomtudományi Kar, Egészségpolitika es Egészség- gazdaságtan Tanszék, Pazmany Peter setany 1/A, Budapest, 1117, Hungary Eötvös Loránd Tudományegyetem, Társadalomtudományi Kar, Egészség-gazdaságtani Kutatóközpont, Pazmany Peter setany 1/A, Budapest, 1117, Hungary Cited By :5 Export Date: 23 June 2021 CODEN: APHGA Correspondence Address: Inotai, A.; Semmelweis Egyetem, Hogyes E. u. 9, Budapest, 1092, Hungary; email: inotai.andras@gytk.sote.hu LA - Hungarian DB - MTMT ER - TY - JOUR AU - Boncz, Imre AU - Nagy, J AU - Korosi, L AU - Kovi, R AU - Molnár, Annamária AU - Kiss, Z AU - Kriszbacher, Ilona Ildikó AU - Varga, Szilárd AU - Sebestyén, Andor TI - THE EFFECT OF THE INTRODUCTION OF VISIT FEE ON THE NUMBER OF PATIENT-VISITS TO OUTPATIENT CARE DEPARTMENTS IN HUNGARY JF - VALUE IN HEALTH J2 - VALUE HEALTH VL - 11 PY - 2008 IS - 6 SP - A368 EP - A369 SN - 1098-3015 DO - 10.1016/S1098-3015(10)66263-8 UR - https://m2.mtmt.hu/api/publication/1172280 ID - 1172280 LA - English DB - MTMT ER - TY - JOUR AU - Boncz, Imre AU - Sebestyén, Andor TI - Financial deficits in the health services of the UK and Hungary JF - LANCET J2 - LANCET VL - 368 PY - 2006 IS - 9539 SP - 917 EP - 918 PG - 2 SN - 0140-6736 DO - 10.1016/S0140-6736(06)69369-0 UR - https://m2.mtmt.hu/api/publication/1362583 ID - 1362583 N1 - Comment on: Lancet. 2006 Jun 24;367(9528):2047-8. LA - English DB - MTMT ER - TY - JOUR AU - Boncz, Imre AU - Nagy, J AU - Sebestyén, Andor AU - Korosi, L TI - Financing of health care services in Hungary JF - EUROPEAN JOURNAL OF HEALTH ECONOMICS J2 - EUR J HEALTH ECON VL - 5 PY - 2004 IS - 3 SP - 252 EP - 258 PG - 7 SN - 1618-7598 DO - 10.1007/s10198-004-0228-3 UR - https://m2.mtmt.hu/api/publication/1363116 ID - 1363116 LA - English DB - MTMT ER - TY - JOUR AU - Gulácsi, László AU - Dávid, T AU - Dózsa, Csaba TI - Pricing and reimbursement of drugs and medical devices in Hungary JF - EUROPEAN JOURNAL OF HEALTH ECONOMICS J2 - EUR J HEALTH ECON VL - 3 PY - 2002 IS - 4 SP - 271 EP - 278 PG - 8 SN - 1618-7598 DO - 10.1007/s10198-002-0148-z UR - https://m2.mtmt.hu/api/publication/1300874 ID - 1300874 AB - Similarly to other countries of Central and Eastern Europe, Hungary has witnessed massive diffusion of healthcare technology such as drugs and medical devices since 1990. While substantial new pharmaceuticals, medical devices, and procedures have been liberalized, there has been no proper evaluation or training in their use. Healthcare providers have come to find themselves as entrepreneurs in private practice, while patients are acquiring an increasing awareness as customers of healthcare, demanding services in return for their taxes and contributions. This has led to extremely irrational patterns of investment in technology, with most an obvious waste of resources, while leaving basic needs unmet. Both the National Health Insurance Fund and the Ministry of Finance believe that the current pharmaceutical and medical device bill is too high. However, introducing a more transparent and flexible pricing and reimbursement framework may enable a more efficient allocation of the limited resources to be achieved. LA - English DB - MTMT ER -